14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CBIO ranks #16620 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Catalyst Biosciences Stock Forecast NASDAQ:CBIO

$4.00 (-3.85%)

Volume: 103k

Closed: Oct 15, 2021

Hollow Logo Score: -4.122

Catalyst Biosciences Stock Forecast

$4.00 (-3.85%)

Volume: 103k

Closed: Oct 15, 2021

Score Hollow Logo -4.122

Catalyst Biosciences Stock Price (Quote) NASDAQ:CBIO

$4.00 ( -3.85% ) Friday, 15th Oct 2021

Range Low Price High Price Comment
30 days $3.59 $5.20 Friday, 15th Oct 2021 CBIO stock ended at $4.00. This is 3.85% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 5.54% from a day low at $3.97 to a day high of $4.19.
90 days $3.59 $5.20
52 weeks $3.59 $7.55

Historical Catalyst Biosciences prices

Date Open High Low Close Volume
2021-10-15 $4.19 $4.19 $3.97 $4.00 103 360
2021-10-14 $4.10 $4.21 $4.08 $4.16 338 811
2021-10-13 $4.10 $4.15 $3.94 $4.10 172 852
2021-10-12 $3.93 $4.11 $3.83 $4.06 207 253
2021-10-11 $3.86 $3.95 $3.81 $3.90 161 457
2021-10-08 $3.87 $3.90 $3.79 $3.85 143 129
2021-10-07 $3.80 $3.86 $3.74 $3.85 229 602
2021-10-06 $3.70 $3.77 $3.59 $3.77 409 705
2021-10-05 $3.91 $3.93 $3.68 $3.70 214 198
2021-10-04 $4.02 $4.07 $3.83 $3.84 288 453
2021-10-01 $4.11 $4.15 $4.00 $4.06 197 935
2021-09-30 $4.18 $4.18 $4.09 $4.11 183 115
2021-09-29 $4.50 $4.50 $4.05 $4.12 374 610
2021-09-28 $4.56 $4.67 $4.46 $4.50 357 626
2021-09-27 $4.77 $5.20 $4.60 $4.63 1 527 863
2021-09-24 $4.88 $4.95 $4.73 $4.74 160 439
2021-09-23 $4.82 $4.91 $4.77 $4.88 134 841
2021-09-22 $4.87 $4.92 $4.77 $4.79 148 431
2021-09-21 $4.92 $5.02 $4.87 $4.87 173 570
2021-09-20 $4.76 $5.05 $4.63 $4.90 363 658
2021-09-17 $4.99 $5.20 $4.91 $5.18 858 442
2021-09-16 $5.05 $5.05 $4.86 $4.99 445 799
2021-09-15 $4.78 $5.18 $4.76 $5.06 731 654
2021-09-14 $4.75 $5.00 $4.63 $4.79 388 905
2021-09-13 $4.65 $4.77 $4.49 $4.76 299 282
2021-09-10 $4.72 $4.84 $4.53 $4.65 1 696 823
2021-09-09 $4.22 $4.49 $4.20 $4.38 353 552
2021-09-08 $4.32 $4.40 $4.18 $4.25 96 492
2021-09-07 $4.45 $4.51 $4.34 $4.34 101 115
2021-09-03 $4.73 $4.73 $4.49 $4.49 168 008
2021-09-02 $4.88 $4.91 $4.52 $4.75 165 992
2021-09-01 $4.59 $4.91 $4.55 $4.82 457 995
2021-08-31 $4.50 $4.73 $4.48 $4.58 326 102
2021-08-30 $4.66 $4.69 $4.42 $4.47 171 673
2021-08-27 $4.35 $4.70 $4.33 $4.66 291 195
2021-08-26 $4.30 $4.44 $4.30 $4.35 118 724
2021-08-25 $4.21 $4.37 $4.15 $4.32 235 848
2021-08-24 $4.12 $4.20 $4.06 $4.20 150 298
2021-08-23 $3.93 $4.18 $3.93 $4.11 221 073
2021-08-20 $3.79 $4.00 $3.72 $3.93 212 235
2021-08-19 $3.88 $3.97 $3.77 $3.78 89 020
2021-08-18 $3.92 $4.01 $3.85 $3.93 118 981
2021-08-17 $4.00 $4.02 $3.87 $3.92 142 840
2021-08-16 $4.09 $4.09 $3.99 $4.02 174 469
2021-08-13 $4.12 $4.14 $4.06 $4.10 78 398
2021-08-12 $4.18 $4.21 $4.11 $4.15 105 630
2021-08-11 $4.20 $4.28 $4.13 $4.19 107 965
2021-08-10 $4.28 $4.33 $4.15 $4.22 180 111
2021-08-09 $4.32 $4.45 $4.26 $4.26 192 215
2021-08-06 $4.17 $4.41 $4.11 $4.37 534 694

About Catalyst Biosciences

Catalyst Biosciences Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT